Cargando…

Development of a quality of life questionnaire for transgender individuals during hormone therapy (iTransQol)

PURPOSE: Quality of life (QoL) is a complex term, including mental, physical and social health, and everyone’s individual environment. While transgender individuals still often report lower QoL than other individuals, they can benefit substantially from gender affirming therapy. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feil, Katharina, Riedl, David, Gschwentner, Lisa, Vomstein, Kilian, Wegscheider, Julia, Arnold, Emanuela, Toth, Bettina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Gynecologic Endocrinology and Reproductive Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470628/ https://www.ncbi.nlm.nih.gov/pubmed/35876907 http://dx.doi.org/10.1007/s00404-022-06689-9

Ejemplares similares

SUN-040 Hormone Replacement Therapy in Transgender Unmasks Testicular Tumor
por: Tran, Kelvin, et al.
Publicado: (2020)

MON-195 Trans-transgender Female: Gender Identity Reversal Following Irreversible Gender Affirming Surgeries
por: Korpaisarn, Sira, et al.
Publicado: (2019)

SUN-048 Cardiometabolic Effects of Cross-Sex Hormone Therapy in Transgender Patients
por: Trebotic, Lana Kosi, et al.
Publicado: (2020)

Effect on Kidney Function During Gender Affirming Hormonal Treatment in Transgender Individuals
por: Maheshwari, Arvind Kumar, et al.
Publicado: (2021)

Prolactinoma in a Male to Female Transgender Woman on Gender Affirming Hormone Therapy
por: Harned, Leighton K, et al.
Publicado: (2021)

Health-related quality of life in patients with polycystic ovary syndrome: validation of the German PCOSQ-G
por: Böttcher, B., et al.
Publicado: (2017)

Development and psychometric properties of the human papillomavirus-quality of life (HPV-QoL) questionnaire to assess the impact of HPV on women health-related-quality-of-life
por: Coronado, Pluvio J., et al.
Publicado: (2022)

MON-LB040 Correlation Between Length of Hormone Therapy and Adverse Events in Transgender Veterans
por: Elliott, Karma-Jaya, et al.
Publicado: (2019)

SUN-LB8 Cross Sex Hormone Therapy and Breast Cancer in Transgender Male to Female
por: Eldin, Randa Sharag, et al.
Publicado: (2020)

SUN-052 Effects of Cross-Sex Hormone Therapy on Lipid Metabolism in Transgender Women and Men
por: Kelley, Carly, et al.
Publicado: (2020)

Patient Characteristics Associated With the Receipt of Hormone Therapy Among Transgender Patients in the Veterans Health Administration
por: Wong, Denise H, et al.
Publicado: (2021)

ODP414 Incidence of Suicidal Events in Transgender Patients with Initiation of Gender Affirming Hormone Therapy
por: Elliott, Karma-Jaya, et al.
Publicado: (2022)

NK and T Cell Subtypes in the Endometrium of Patients with Recurrent Pregnancy Loss and Recurrent Implantation Failure: Implications for Pregnancy Success
por: Braun, Anne-Sophie, et al.
Publicado: (2023)

Higher Prevalence of Adverse Childhood Experiences in Transgender Than in Cisgender Individuals: Results from a Single-Center Observational Study
por: Feil, Katharina, et al.
Publicado: (2023)

Predicting success of intrauterine insemination using a clinically based scoring system
por: Zippl, Anna Lena, et al.
Publicado: (2022)

MON-197 Peri-operative Outcomes of Vaginoplasty Using an Individualized Approach to Hormone Management in Transgender Women
por: Davidge-Pitts, Caroline, et al.
Publicado: (2019)

Muscle Strength in Transgender Women After Long-Term Hormone Therapy: A Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

Body Composition of Transgender Women After Long-Term Hormone Therapy - a Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
por: Da Silva, Eliane Dias, et al.
Publicado: (2021)

Immunological Risk Factors in Recurrent Pregnancy Loss: Guidelines Versus Current State of the Art
por: Vomstein, Kilian, et al.
Publicado: (2021)

PMON280 Effect of Gender Affirming Hormone Therapy (GAHT) on Adipose Tissue Morphology and Metabolism in Transgender Individuals
por: Shah, Manasi S, et al.
Publicado: (2022)

Recurrent Spontaneous Miscarriage: a Comparison of International Guidelines
por: Vomstein, Kilian, et al.
Publicado: (2021)

OR27-05 Sexual Desire Changes in Transgender Individuals upon Initiation of Hormone Treatment; Results from the Longitudinal ENIGI Study
por: Defreyne, Justine, et al.
Publicado: (2020)

Cardiovascular Risk Factors in Transgender Women Undergoing Long-Term Gender-Affirming Hormone Therapy: A Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

A Cross Sectional Analysis of the Prevalence of Co-Morbidities in Older Transgender Individuals Receiving Hormone Affirming Therapy in Comparison With the General Population
por: Breda, Ido, et al.
Publicado: (2021)

First Evidence of Cardiopulmonary Adaptation to Physical Effort in Transgender Women After Long-Term Hormone Therapy: A Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

Are uterine natural killer and plasma cells in infertility patients associated with endometriosis, repeated implantation failure, or recurrent pregnancy loss?
por: Freitag, Nadine, et al.
Publicado: (2020)

SUN-043 Galactorrhea and Hyperprolactinemia in a Transgender Female
por: Unnithan, Rachna, et al.
Publicado: (2020)

Multicenter Analysis of Cardiometabolic-Related Diagnosesin Transgender Adolescents
por: Valentine, Anna, et al.
Publicado: (2021)

LBSAT133 Dilemmas In The Diagnosis Of Osteoporosis In Transgender Population
por: Vasanthaakumar, Vijaykiran P, et al.
Publicado: (2022)

OR25-5 High Prevalence of Psychopathologies Among Transgender Subjects Presenting at a Large Tertiary Transgender Health Center: Implication for the Treating Clinicians
por: Kerem, Gil, et al.
Publicado: (2019)

Plasma sclerostin levels are associated with nutritional status and insulin resistance but not hormonal disturbances in women with polycystic ovary syndrome
por: Wyskida, Katarzyna, et al.
Publicado: (2020)

Seasonal dynamic of cholecalciferol (D3) and anti-Muellerian hormone (AMH) with impact on ovarian response and IVF/ICSI
por: Rogenhofer, Nina, et al.
Publicado: (2022)

“It Wasn’t for the Sake of Me and My Mental Health”: Transgender People’s Perspective on the Role of Mental Health Providers in Initiating Gender-Affirming Hormones - a Qualitative Study
por: Maksutova, Mariam, et al.
Publicado: (2021)

RF34 | PMON276 The Effect of Gender Affirming Hormone Therapy (GAHT) on Non-Conventional Cardiovascular Risk Markers in Transgender Men: A Systematic Review
por: Moreira Allgayer, Roberta Martins Costa, et al.
Publicado: (2022)

Does anti-Mullerian hormone predict the outcome of further pregnancies in idiopathic recurrent miscarriage? A retrospective cohort study
por: Pils, Sophie, et al.
Publicado: (2018)

Different Background: Natural Killer Cell Profiles in Secondary versus Primary Recurrent Pregnancy Loss
por: Strobel, Laura, et al.
Publicado: (2021)

Management of Recurrent Deep Vein Thrombosis in a Transgender Woman
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

Stability of Weekly Intramuscular Estradiol Cypionate in a Transgender Woman
por: Calzada, Stephanie, et al.
Publicado: (2021)

Differences in the lipid profile and hormone replacement therapy use in Korean postmenopausal women: the Korea National Health and Nutrition Examination Survey (KNHANES) 2010–2012
por: Ki, Eun Young, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_44o5g1h83vmu51k1574dqvvg0c